Compounds for treating and preventing cognitive diseases and depression and methods of making same
AssigneeHoffman-LaRoche Inc.
InventorsWalter Gassner, Rene Imhof
Life of this patent
Estimating the term…
Loading patent…
AssigneeHoffman-LaRoche Inc.
InventorsWalter Gassner, Rene Imhof
Estimating the term…
Ethylenediamine monoamides of the formula R--CO--NH--CH.sub.2 --CH.sub.2 --NH.sub.2 I wherein R is one of groups ##STR1## in which R.sup.1 is phenyl, monohalophenyl, monolower-alkylphenyl, monolower-alkoxyphenyl, monotrifluoromethylphenyl, monocyanophenyl or monaryl-lower-alkoxyphenyl, dihalophenyl, furyl, thienyl or monohalothienyl, R.sup.2 is hydrogen, halogen or amino, R.sup.3, R.sup.5 and R.sup.7 each are phenyl, monohalophenyl, dihalophenyl, thienyl, furyl or monohalofuryl, R.sup.4 and R.sup.6 each are hydrogen or amino and R.sup.8 is hydrogen or lower-alkyl, as well as their pharmaceutically usable acid addition salts are disclosed. The compounds have monoamine oxidase inhibiting properties with low toxicity and are useful for the treatment of depressive states and cognitive disorders.
A compound of formula R--CO--Y wherein R is one of the groups ##STR5## and Y is a group --NH--CH.sub.2 --CH.sub.2 --R.sup.14 ;
A compound of the formula R--CO--Y wherein R is one of the groups ##STR6## and Y is a group --NH--CH.sub.2 --CH.sub.2 --R.sup.14, in which R.sup.1 is phenyl, monohalophenyl, monolower-alkylphenyl, monocyanophenyl, monoaryl-lower-alkoxyphenyl, dihalophenyl, furyl, thienyl or monohalothienyl;
Dependencies are inferred from the claim text.